Biome Australia Limited (ASX:BIO) Reports Strong Q3 FY25 Sales Growth
Financial Performance
Biome Australia Limited (ASX:BIO) reported a 41% increase in Q3 FY25 sales revenue, reaching approximately $4.5 million compared to Q3 FY24. The financial year to date sales revenue stands at around $13.4 million, reflecting a 46% growth. Same-store-sales also grew by 45% over the last three months.
Awards and Recognition
Biome was named Terry White Chemmart Retail Supplier of the Year, outperforming major companies in the pharmaceuticals and vitamins industry. This accolade highlights Biome’s strong sales growth and service in the community pharmacy sector.
Future Outlook
The company expects to report another quarter of positive EBITDA for Q3 and aims for its first full year of net profit. Biome plans to launch new products and acquire new customers both locally and internationally in the upcoming quarter.
Executive Comments
Biome Australia’s Managing Director and Founder, Blair Vega Norfolk, commented:
“I am excited to share this result for Q3 FY25, another strong quarter in sales revenue. March quarter is seasonally the slowest quarter in the industry, due to reduced trading days as well as pharmacy and practitioner customers being on school holidays. The team and I are thrilled with the steps forward made in Q3 backing up our record quarter in Q2 in less trading days. As we enter the June quarter, Biome and our Activated Probiotics are well positioned for significant growth to close the financial year, aiming for our first full year of net profit. During Q4, there will be a number of new product launches and new customers commencing trading both locally and abroad. We look forward to sharing updates on these new innovations with the market throughout the quarter.”
Motley Fool contributor Aaron Shaw has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
